Optimizing Exercise as Therapy in Cardiopulmonary Disease


The research focus of the Brown Lab for Optimization of Exercise as Therapy in Cardiopulmonary Disease is all about improving how exercise is used as medicine!  Exercise is an underutilized therapy, in part because insufficient data is available to assist practitioners in its appropriate prescription for specific patient groups. Much of Dr. Brown’s research to date has been to address this gap specifically for patients with lung disease, including pulmonary arterial hypertension, pulmonary embolism, cystic fibrosis, and lymphangioleiomyomatosis (LAM). Her clinical and animal studies aim to define the physiological and biochemical consequences and functional outcomes following acute and chronic exercise in lung disease, to permit much needed optimization of exercise prescription for patients.

Dr. Brown’s research funding is from the National Heart, Lung, Blood Institute of the NIH, The American Heart Association Scientist Development Grant, The Pulmonary Hypertension Association, The American Thoracic Society, and The Lymphangioleiomyomatosis Association.

Poster presentation at CSM 2023
Lab gathering at CSM 2023 in San Diego
Tor and Dan at their platform presentation at CSM 2023
Brenna, Beth, and Claire at LAM Annual Meeting 2022 Chicago